Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Identification and Cloning of a Fraction 1 Protein of Yersinia pestis that Produces Protective Immune Responses

  • Kim Jong-Hyun (Division of Enteric Bacterial Infections, Center for Infectious Diesease, National Institute of Health) ;
  • Cho Seung-Hak (Division of Enteric Bacterial Infections, Center for Infectious Diesease, National Institute of Health) ;
  • Jang Hyun-Chul (Division of Enteric Bacterial Infections, Center for Infectious Diesease, National Institute of Health) ;
  • Lee Hee-Cheul (Division of Enteric Bacterial Infections, Center for Infectious Diesease, National Institute of Health) ;
  • Kim Young-Il (Division of Enteric Bacterial Infections, Center for Infectious Diesease, National Institute of Health) ;
  • Kang Yeon-Ho (Division of Enteric Bacterial Infections, Center for Infectious Diesease, National Institute of Health) ;
  • Lee Bok-Kwon (Division of Enteric Bacterial Infections, Center for Infectious Diesease, National Institute of Health)
  • Published : 2006.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

The capsule that surrounds Yersinia pestis cells is composed of a protein-polysacchride complex; the purified protein component is fraction I (F1) antigen. We report the cloning of the cafl gene and its expression in Escherichia coli using the vector pETl02/D-TOPO and the F1-specific monoclonal antibody. The recombinant F1 (rF1) antigen had a molecular size of 17.5 kDa, which was identical to that of the F1 antigen produced by Y. pestis. Recombinant F1 protein was found to react to polyclonal antiserum to Y. pestis Fl. Recombinant F1 was purified by ProBond purification system and induced a protective immune response in BALB/c mice challenged with up to 10$^5$ virulent Y. pestis. Purified rF1 protein was used in an ELISA to evaluate the ability of a method to detect antibodies to Y. pestis in animal sera. These results strongly indicated that the rF1 protein is a suitable species-specific immunodiagnostic antigen and vaccine candidate.

Keywords

References

  1. Anderson, G. W., D. G. Heath, C. R. Bolt, S. L. Welkos, and A. M. Friedlander. 1998. Short and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58: 793-799 https://doi.org/10.4269/ajtmh.1998.58.793
  2. Anderson, G. W., P. L. Worsham, C. R. Bolt, G. P. Andrews, S. L. Welkos, A. M. Friedlander, and J. P. Burans. 1997. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am. J. Trop. Med. Hyg. 56: 471-473 https://doi.org/10.4269/ajtmh.1997.56.471
  3. Baker, E. E., H. Sommer, L. E. Foster, E. Meyer, and K. F. Meyer. 1952. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis.J. Immunol. 68: 131-145
  4. Bennett, L. G and T. G. Tornabene. 1974. Characterization of the antigenic subunits of the envelope protein of Yersinia pestis. J. Bacteriol. 117: 48-55
  5. Butler, T. 1984. Plague, pp. 834-838. In K. S Warren and A. A. Mahmoud (eds.), Tropical and Geographical Medicine. McGraw-Hill, New York, N.Y
  6. Cowling, P. and P. Moss. 1994. Infectivity of pneumonic plague. Br. Med. J. 309: 1369
  7. Davis, K. M., D. L. Fritz, L. M. Pitt, S. L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys. Arch. Pathol. Lab. Med. 120: 156-163
  8. Devdariani, Z. L., M. S. Verenkov, V. A. Feodorova, N. S. Solodovnicov, and L. G. Belov. 1993. Identification of Yersinia pestis with varied plasmid composition using monoclonal and polyclonal fluorescent immunoglobulins. FEMS. Immunol. Med. Microbiol. 6: 31-35 https://doi.org/10.1111/j.1574-695X.1993.tb00300.x
  9. Galyov, E. E., O. Y. Smirnov, A. V. Karlishev, K. I. Volkovoy, A. I. Denesyuk, I. V. Nazimov, K. S. Rubstov, V. M. Abramov, S. M. Dalvadyanz, and V. P. Zav'yalov. 1990. Nucleotide sequence of Yersinia pestis gene encoding FI antigen and the primary structure of the protein. FEBS Lett. 277: 230-232 https://doi.org/10.1016/0014-5793(90)80852-A
  10. Kim, J.-H., S.-K. Choi, W.-J. Lim, and H.-I. Chang. 2004. Protective effect of astaxanthin produced by Xanthophyllomyces dendrorhous mutant on indomethacininduced gastric mucosal injury in rats. J. Microbiol. Biotechnol. 14: 996-1003
  11. Kim, K.-Y., B.-S. Koo, D. Jo, and S.-I. Kim. 2004. Cloning, expression, and purification of exoinulinase from Bacillus sp. snu-7. J. Microbial. Biotechnol. 14: 344-349
  12. Ljungstrom, I., G. Huldt, and A. Voller. 1974. The effect of Eperythrozoon cocco ides infection on the number of plaque forming cells in mice. Acta Pathol. Microbial. Scand. Sect. B Microbiol. Immunol. 82: 911-913
  13. Meyer, K. F. 1970. Effectiveness of live or killed plague vaccines in man. Bull. World Health Organ. 42: 653-666
  14. Reed, L. J. and H. A. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27: 493-497
  15. Rodrigues, C. G., C. M. Carneiro, C. T. Barbosa, and R. A. Nogueira. 1992. Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes. Braz. J. Med. Biol. Res. 25: 75-79
  16. Sambrook, J. and D. W. Russel (eds.). 2001. Molecular Cloning: A Laboratory Manual, 3rd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  17. Shepherd, A. J., D. E. Hummitzsch, P. A. Leman, R. Swanepoel, and L. A. Searle. 1986. Comparative tests for detection of plague antigen and antibody in experimentally infected wild rodents. J. Clin. Microbiol. 24: 1075-8
  18. Welkos, S. L., K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Friedlander. 1995. Studies on the contribution of the F1-capsule-associated plasmid pFra to the virulence of Yersin ia pestis. Contrib. Microbiol. Immunol. 13: 299-305
  19. Williamson, E. D., S. M. Eley, A. J. Stagg, M. Green, P. Russell, and R. W. Titball, 1997. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15: 1079-1084 https://doi.org/10.1016/S0264-410X(96)00303-9
  20. Willians, J. E., L. Arntzen, G. L. Tyndal, and M. Isaacson. 1986. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia. Bull. World Health Organ. 64: 745-752
  21. Xu, W., L. Beati, and D. Raoult. 1997. Characterization of and application of monoclonal antibodies against Rickettsia africae, a newly recognized species of spotted fever group rickettsia. J. Clin. Microbiol. 35: 64-70